Malaria Drug Accelerator (MalDA)

The Malaria Drug Accelerator – MalDA (Formerly MDTIP) is a collaboration funded by the Bill and Melinda Gates foundation to use chemogenomic methods to identify the drug target and mechanism of action for the fifty most prominent compounds in the Malaria Box.

MalDA Members

Bill and Melinda Gates Foundation
Bill and Melinda Gates Foundation

Omar Vandal

David Fidock Lab at Columbia University
David Fidock Lab at Columbia University

Manu Vanaerschot

Pennsylvania State University
Pennsylvania State University

Manuel Llinas

Dyann Wirth Lab at Harvard University
Dyann Wirth Lab at Harvard University

Pamela Magistrado
Amanda Lukens

Daniel Goldberg Lab at Washington University in St. Lous
Daniel Goldberg Lab at Washington University in St. Lous

Eva Istvan

Elizabeth Winzeler Lab at UC San Diego
Elizabeth Winzeler Lab at UC San Diego

Purva Gupta
Sabine Ottilie

GlaxoSmithKline
GlaxoSmithKline

Francisco Javier Gamo-Benito

Wellcome Trust Sanger Institute
Wellcome Trust Sanger Institute

Marcus Lee

The Medicines For Malaria Venture
The Medicines For Malaria Venture

Paul Willis

Message us for inquiries regarding the MalDA project

Contact Us

Start typing and press Enter to search